Ipsen (Euronext: IPN; ADR: IPSEY) has completed its acquisition of Memo Therapeutics AG, a late-stage biotech company focused on potravitug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Mergers and Acquisitions